ARTICLE | Distillery Therapeutics
SLC12A5, Rho kinase as targets for mutation-associated intellectual disability
January 30, 2021 1:16 AM UTC
DISEASE CATEGORY: Neurology
INDICATION: Cognitive dysfunction...
BCIQ Company Profiles
Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
DISEASE CATEGORY: Neurology
INDICATION: Cognitive dysfunction...
BCIQ Company Profiles
BCIQ Company Profiles